comparemela.com

Latest Breaking News On - Novarti xiidra - Page 1 : comparemela.com

Why Aldeyra Is A Must-Watch Stock: Exciting Catalysts On The Horizon

2023 is shaping up to be a pivotal year for Aldeyra Therapeutics Inc. (ALDX) as it continues to make significant progress in its pipeline of compounds targeting systemic and retinal immune-mediated diseases.

Aldeyra Prepares to Submit Dry Eye Disease Treatment to FDA

Aldeyra Therapeutics reported that its reproxalap hit the mark in the Phase III Tranquility-2 study for dry eye disease. The drug showed statistical superiority for its two primary endpoints.

Oyster Point s drug becomes first FDA-approved nasal spray to treat dry eyes

Oyster Point s drug becomes first FDA-approved nasal spray to treat dry eyes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Oyster Point sells China rights to nasal sprays for eye disease

Oyster Point sells China rights to nasal sprays for eye disease
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.